English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/181391
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

AuthorsGallego-Durán, Rocío; Cerro-Salido, Pablo; Gómez-González, Emilio; Pareja, María Jesús; Ampuero, Javier; Rico, María Carmen; Aznar, Rafael; Vilar-Gómez, Eduardo; Bugianesi, Elisabetta; Crespo García, Javier; González-Sánchez, Francisco José; Aparcero, Reyes; Moreno-Santos, Inmaculada; Soto, Susana; Arias-Loste, María Teresa; Abad, Javier; Ranchal, Isidora; Andrade, Raúl J.; Calleja, José Luis; Pastrana, Miguel; Lo lacono, Oreste; Romero-Gómez, Manuel
Issue Date12-Aug-2016
PublisherSpringer Nature
CitationScientific Reports 6: 31421 (2016)
AbstractThere is a need, in NAFLD management, to develop non-invasive methods to detect steatohepatitis (NASH) and to predict advanced fibrosis stages. We evaluated a tool based on optical analysis of liver magnetic resonance images (MRI) as biomarkers for NASH and fibrosis detection by investigating patients with biopsy-proven NAFLD who underwent magnetic resonance (MR) protocols using 1.5T General Electric (GE) or Philips devices. Two imaging biomarkers (NASHMRI and FibroMRI) were developed, standardised and validated using area under the receiver operating characteristic curve (AUROC) analysis. The results indicated NASHMRI diagnostic accuracy for steatohepatitis detection was 0.83 (95% CI: 0.73–0.93) and FibroMRI diagnostic accuracy for significant fibrosis determination was 0.85 (95% CI: 0.77–0.94). These findings were independent of the MR system used. We conclude that optical analysis of MRI has high potential to define non-invasive imaging biomarkers for the detection of steatohepatitis (NASHMRI) and the prediction of significant fibrosis (FibroMRI) in NAFLD patients.
Publisher version (URL)https://doi.org/10.1038/srep31421
URIhttp://hdl.handle.net/10261/181391
DOI10.1038/srep31421
E-ISSN2045-2322
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
srep31421.pdf498,42 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.